MRE Biomarker Ctte: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 14: | Line 14: | ||
'''Approved call summaries:''' | '''Approved call summaries:''' | ||
*[[Media:2017_01-30_QIBA_MRE_BC_Call_Summary-FINAL.pdf|January 30, 2017]] | |||
*[[Media:2016_11-07_QIBA_MRE_BC_Call_Summary-FINAL.pdf|November 7, 2016]] | *[[Media:2016_11-07_QIBA_MRE_BC_Call_Summary-FINAL.pdf|November 7, 2016]] | ||
'''''[[MRE BC Call Summaries Archive]]''''' | '''''[[MRE BC Call Summaries Archive]]''''' | ||
==MRE Profile Development== | ==MRE Profile Development== | ||
Revision as of 21:02, 9 April 2018
- Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD
- Secretary: Susan Stanfa
Project Snapshot
The MRE Biomarker Committee seeks to develop a quantitative Profile for MRE.
MRE Profile to be data-driven:
- focusing on the characterization of bias and precision in MRE measurement targets for achieving these measurements
- focusing on issues important to specific reproducibility
Meetings
Approved call summaries:
MRE Profile Development